Avantor, Inc. (AVTR)
Health Care / Life Sciences Tools & Services
S&P MidCap 400$7.77
Scores poorly across most models. Proceed with caution.
Avoid
Score based on 4 of 5 models — moderate confidence
Is Avantor, Inc. a Good Investment in 2026?
Avantor, Inc. (AVTR) scores 1.7 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model rates Avantor, Inc. as Attractive (6/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 91%). Avantor, Inc. ranks #1103 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
6/9
Buffett
Caution
Business quality & competitive moat
Graham
Caution
Price vs intrinsic value
Lynch
Attractive
Growth rate vs price (PEG)
Greenblatt
Caution
Bottom half (rank 91%)
Frequently Asked Questions
Is Avantor, Inc. (AVTR) a good investment?
What is Avantor, Inc.'s Piotroski F-Score?
Is AVTR overvalued or undervalued?
How does AVTR compare to other Health Care stocks?
What do investment models say about AVTR?
Similar Stocks
Compare AVTR with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer